According to the report published by Visiongain, the Women’s Health Diagnostics market was valued at approximately USD xx billion in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030. Women are expected to drive the market during the forecast period by rising prevalence of infectious diseases, including hepatitis and urinary tract infection. It is vital that electronic and wearable mammograms such as breast MRI, ultrasound or bone density assessments can be used to diagnose any health problems early. Medical advances provide lucrative possibilities to monitor women’s-centric conditions including infectious diseases, osteoporosis, and breast cancer. It is estimated that this works for the market. Women are 30.0% more prone to HIV infection compared to men according to data published by the National Center for Biotechnology Information (NCBI). Women are expected to drive the market over the duration of forecasting and raise their incidence of infectious diseases, such as hepatitis and urinary tract infection.
Countries have endorsed global efforts to promote women’s health through the adoption of the 2030 Sustainable Development Agenda. The Sustainable Development Goals and the Global Strategy for Women, Kids and Adolescent Health are being pushed forward. The 66th session of the WHO Regional Committee for Europe will be considered in September 2016 to reinforce action as part of progress in the Health 2020 agenda, a women’s health and well-being Strategy in the 2017-2021 WHO European Region. The background to the strategy is provided in this report. It presents an instantaneous overview of women’s health in the region, analyzes the social, economic and environmental factors affecting women’s health and well-being, focuses on the impact of gender discrimination and gender stereotypes, takes into consideration what the concept of human centered health systems should be used to meet women’s needs and regards important perspectives.
Countries have supported global efforts to promote women’s health through the adoption of the Sustainable Development Strategy for 2030. The Sustainable Development Goals and Global Strategy are being pursued to support women, children and young people’s health. The WHO Regional Committee for Europe’s 66th Session 2016 will be considered in order to strengthen action as part of advancing the Agenda for Health 2020, a Strategy on Women’s Health and Well-being in the European WHO Region 2017–2021. The strategy is backed by this report. It presents a snapshot of the health of women within the Region, discusses Social, Economic and Environmental Factors, that determines the health and well-being of women, focuses on the impact of discrimination based on gender and gender stereotyping, considers what the concept of human health systems needs in order to address the needs of women.
The industry was categorized into cancer screening, diabetes monitoring, osteoporosis testing, maternity & reproduction testing and prenatal testing depending on use. In 2017, cancer dominated the market by introducing hybrid imaging instruments that were technologically advanced with increased precision. Quest Diagnostics, for example, acquired Med Fusion and Clear Point laboratories in Texas in July 2017 to expand its laboratory business to diagnose women’s cancer.
Various partnerships between key players, policymakers and other organizations are able to support market growth, improving patient exposure to the treatment of different diseases. In November 2017, for example, the BGI and the Tanenbaum Research Institute of Lunen Feld signed a joint agreement on developing a genomic early diagnostic test for premature birth and other complications for women who are susceptible of pregnancy.
The largest share of women’s diagnostic health markets in 2019 was represented by hospitals and diagnostic centers. The category will retain its market position by 2025, since physicians are typically the first option to detect cancer, infectious disease and osteoporosis, among other issues. During the period forecast, the home segment should see lucrative growth as market players invest in the commercialization of mobile and point-of-service equipment. In addition, increasing awareness of home diagnostic devices is estimated to boost the segment’s growth.
Why you should buy Women’s Health Diagnostics Market Forecast 2020-2030
What is the future of the Women’s Health Diagnostics market? Vision gain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information
• View Women’s Health Diagnostics market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Women’s Health Diagnostics revenue forecast
– Women’s Health Diagnostics connections forecast
• Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Women’s Health Diagnostics market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Women’s Health Diagnostics sector
• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Women’s Health Diagnostics industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organization can succeed. Avoid falling behind. Stay informed about the potential for each of these Women’s Health Diagnostics submarkets with individual forecasts and analysis from 2020-2030.
– Application submarket forecast 2020-2030
– End-Use submarket forecast 2020-2030
– Submarket forecast 2020-2030
• Learn about the market prospects for the leading Women’s Health Diagnostics market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Women’s Health Diagnostics revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Application Revenue Forecast 2020-2030
– Cancer revenue forecast 2020-2030
– Breast Cancer Testing revenue forecast 2020-2030
– Cervical Cancer Testing revenue forecast 2020-2030
– Ovarian Cancer Testing revenue forecast 2020-2030
– Infectious Disease Testing revenue forecast 2020-2030
– Osteoporosis Testing revenue forecast 2020-2030
– Pregnancy and Fertility Testing revenue forecast 2020-2030
– Prenatal Testing revenue forecast 2020-2030
– Other Application revenue forecast 2020-2030
– End-Use Revenue Forecast 2020-2030
– Hospitals and Clinics revenue forecast 2020-2030
– Home Care Settings revenue forecast 2020-2030
– Diagnostic and Imaging Centers revenue forecast 2020-2030
– Other End-Use revenue forecast 2020-2030
• Understand the prospects for the 4 regional and the leading 12 national Women’s Health Diagnostics markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Women’s Health Diagnostics companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
• Explore the factors affecting Women’s Health Diagnostics product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialization by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
• Identify who the leading companies are in the Women’s Health Diagnostics industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View vision gain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Women’s Health Diagnostics companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Women’s Health Diagnostics Market
The main strategies used by market players to remain competitive include mergers and acquisitions, partnerships, and regional presence enlargement. Quest Diagnostics, for example, acquired in September 2017 two HHC hospitals, the Hospital of Central Connecticut and the Hospital of William W. Backus, in order to improve its laboratory services. Hologic, Inc. entered a strategic alliance with Quest Diagnostics in June 2013 in order to expand its product product range in the women’s health diagnostics segment of Aptima products. Furthermore, in September 2016, GE Healthcare entered into a partnership with Trice Imaging, Inc. for Tricefy, a cloud-based image sharing solution. This partnership enhanced its ultrasound women’s health product portfolio.
Siemens Aktiengesellschaft
Dialab Gmbh
Fujifilm Medical Systems USA
Medgyn Products, Inc.
Thermo Fisher Scientific, Inc.
Genmark Diagnostics
Immco Diagnostics
Siemens Healthcare GmBH
Hologic, Inc.
GE Healthcare
F. Hoffmann-La Roche Ltd
Discover Information found nowhere else in this independent assessment of the Women’s Health Diagnostics market
The Women’s Health Diagnostics Market Forecast 2020-2030: Forecasts and Analysis By Application, By End-Use, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Women’s Health Diagnostics sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Vision gain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Women’s Health Diagnostics Market Forecast 2020-2030: Forecasts and Analysis By Application, By End-Use, By and and Geography, with Profiles of Leading Companies report can benefit you
Vision gain’s report is for anyone requiring analysis of the Women’s Health Diagnostics market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Women’s Health Diagnostics sector and find out what its future market prospects are.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Women’s Health Diagnostics Market Forecast 2020-2030: Forecasts and Analysis by Application, by End-use, and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Women’s Health Diagnostics Market Definition
1.2 Global Women’s Health Diagnostics Market Overview
1.3 Global Women’s Health Diagnostics Market Segmentation
1.4 Research Scope of Women’s Health Diagnostics in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Women’s Health Diagnostics Systems Market
2.1 Market Definition
2.2 Industry Outlook
2.3 Value Chain Analysis
2.4 Industry Structure
2.5 Current Status & Trends
2.6 Demand & Supply Analysis
2.7 Trade Analysis
2.8 Price Trend Analysis
3. Global Women’s Health Diagnostics Market Analysis
3.1 PEST Analysis of the Women’s Health Diagnostics Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Women’s Health Diagnostics Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.2 Supplier Power
3.9.3 Buyer Power
3.9.4 Threat of Substitute
3..9.5 Threat of New Entrant
4. Women’s Health Diagnostics: Global Market Analysis by Segments
4.1 Global Women’s Health Diagnostics Market Forecast, by Application 2020-2030
4.1.1 Application Overview
4.1.2 Cancer Market Forecast, 2020-2030
4.1.2.1 Breast Cancer Testing Market Forecast, 2020-2030
4.1.2.2 Cervical Cancer Testing Market Forecast, 2020-2030
4.1.2.3 Ovarian Cancer Testing Market Forecast, 2020-2030
4.1.3 Infectious Disease Testing Market Forecast, 2020-2030
4.1.4 Osteoporosis Testing Market Forecast, 2020-2030
4.1.5 Pregnancy and Fertility Testing Market Forecast, 2020-2030
4.1.6 Prenatal Testing Market Forecast, 2020-2030
4.1.7 Other Application Market Forecast, 2020-2030
4.2GlobalWomen’sHealthDiagnosticsMarketForecast,byEndUse2020-2030
4.2.1EndUseOverview
4.2.2HospitalsandClinicMarketForecas2020-2030
4.2.3HomeCareSettingsMarketForecast,2020-2030
4.2.4DiagnosticandImagingCentersMarketForecast,2020-2030
4.2.5 Other End Use Market Forecast, 2020-2030
5. Leading Regions in Women’s Health Diagnostics Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Women’s Health Diagnostics Market Forecast, 2020-2030
5.2.1 North America Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
5.2.2 North America Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030
5.2.3 North America Women’s Health Diagnostics Submarket, By ZZZZ Forecast 2020-2030
5.2.4 North America Women’s Health Diagnostics Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Women’s Health Diagnostics Market, Forecast 2020-2030
5.2.4.2 Canada Women’s Health Diagnostics Market, Forecast 2020-2030
5.2.4.3 Mexico Women’s Health Diagnostics Market, Forecast 2020-2030
5.3 Europe Women’s Health Diagnostics Market Forecast, 2020-2030
5.3.1 Europe Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
5.3.2 Europe Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030
5.3.3 Europe Women’s Health Diagnostics Submarket, By ZZZZ Forecast 2020-2030
5.3.4 Europe Women’s Health Diagnostics Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Women’s Health Diagnostics Market, Forecast 2020-2030
5.3.4.2 Germany Women’s Health Diagnostics Market, Forecast 2020-2030
5.3.4.3 France Women’s Health Diagnostics Market, Forecast 2020-2030
5.3.4.4 Italy Women’s Health Diagnostics Market, Forecast 2020-2030
5.3.4.5 Spain Women’s Health Diagnostics Market, Forecast 2020-2030
5.3.4.6 The Netherlands Women’s Health Diagnostics Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Women’s Health Diagnostics Market, Forecast 2020-2030
5.4 Asia-Pacific Women’s Health Diagnostics Market Forecast, 2020-2030
5.4.1 Asia-Pacific Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
5.4.2 Asia-Pacific Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030
5.4.3 Asia-Pacific Women’s Health Diagnostics Submarket, By ZZZZ Forecast 2020-2030
5.4.4 Asia-Pacific Women’s Health Diagnostics Submarket, By Country Forecast 2020-2030
5.4.4.1 China Women’s Health Diagnostics Market, Forecast 2020-2030
5.4.4.2 India Women’s Health Diagnostics Market, Forecast 2020-2030
5.4.4.3 Japan Women’s Health Diagnostics Market, Forecast 2020-2030
5.4.4.4 Korea Women’s Health Diagnostics Market, Forecast 2020-2030
5.4.4.5 Indonesia Women’s Health Diagnostics Market, Forecast 2020-2030
5.4.4.6 Australia Women’s Health Diagnostics Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Women’s Health Diagnostics Market, Forecast 2020-2030
5.5 Rest of World Women’s Health Diagnostics Market Forecast, 2020-2030
5.5.1 Rest of World Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
5.5.2 Rest of World Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030
5.5.3 Rest of World Women’s Health Diagnostics Submarket, By ZZZZ Forecast 2020-2030
6. Leading Companies in The Women’s Health Diagnostics Market
6.1 Medgyn Products, Inc.
6.1.1 Medgyn Products, Inc. Overview
6.1.2 Analysis of Medgyn Products, Inc. Products and Services
6.1.3 Medgyn Products, Inc. Primary Market Competitors 2019
6.1.4 Medgyn Products, Inc. Key Developments
6.2 Thermo Fisher Scientific, Inc.
6.2.1 Thermo Fisher Scientific, Inc. Company Overview
6.2.2 Analysis of Thermo Fisher Scientific, Inc. Products and Services
6.2.3 Thermo Fisher Scientific, Inc. Primary Market Competitors 2019
6.2.4 Thermo Fisher Scientific, Inc. Key Developments
6.3 Siemens Aktiengesellschaft
6.3.1 Siemens Aktiengesellschaft Company Overview
6.3.2 Analysis of Siemens Aktiengesellschaft Products and Services
6.3.3 Siemens Aktiengesellschaft Primary Market Competitors 2019
6.3.4 Siemens Aktiengesellschaft Key Developments
6.4 Dialab Gmbh
6.4.1 Dialab Gmbh Company Overview
6.4.2 Analysis of Dialab Gmbh Products and Services
6.4.3 Dialab Gmbh Primary Market Competitors 2019
6.4.4 Dialab Gmbh Key Developments
6.5 Fujifilm Medical Systems Usa
6.5.1 Fujifilm Medical Systems Usa Company Overview
6.5.2 Analysis of Fujifilm Medical Systems Usa Products and Services
6.5.3 Fujifilm Medical Systems Usa Primary Market Competitors 2019
6.5.4 Fujifilm Medical Systems Usa Key Developments
6.6 Genmark Diagnostics
6.6.1 Genmark Diagnostics Company Overview
6.6.2 Analysis of Genmark Diagnostics Products and Services
6.6.3 Genmark Diagnostics Primary Market Competitors 2019
6.6.4 Genmark Diagnostics Key Developments
6.7 Immco Diagnostics
6.6.1 Immco Diagnostics Company Overview
6.6.2 Analysis of Immco Diagnostics Products and Services
6.6.3 Immco Diagnostics Primary Market Competitors 2019
6.6.4 Immco Diagnostics Key Developments
6.8 Siemens Healthcare GmBH
6.8.1 Siemens Healthcare GmBH Company Overview
6.8.2 Analysis of Siemens Healthcare GmBH Products and Services
6.8.3 Siemens Healthcare GmBH Primary Market Competitors 2019
6.8.4 Siemens Healthcare GmBH Key Developments
6.9 Hologic, Inc.
6.9.1 Hologic, Inc. Company Overview
6.9.2 Analysis of Hologic, Inc. Products and Services
6.9.3 Hologic, Inc. Primary Market Competitors 2019
6.9.4 Hologic, Inc. Key Developments
6.10 GE Healthcare
6.10.1 GE Healthcare Company Overview
6.10.2 Analysis of GE Healthcare Products and Services
6.10.3 GE Healthcare Primary Market Competitors 2019
6.10.4 GE Healthcare Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Women’s Health Diagnostics Market Segmentation
Figure 2.1 Women’s Health Diagnostics Value Chain Analysis
Figure 3.1 Women’s Health Diagnostics Supply-Demand Analysis
Figure 4.1 Global Women’s Health Diagnostics Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Women’s Health Diagnostics Market Forecast 2020-2030
Figure 4.3 Global Women’s Health Diagnostics Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Women’s Health Diagnostics Market By Application Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.19 Global Women’s Health Diagnostics by Submarket By Application Forecast 2020-2030 ($ million)
Figure 4.20 Global Women’s Health Diagnostics Market, by Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.21 Women’s Health Diagnostics Market, By End Use Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Women’s Health Diagnostics Market, By ZZZZ System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Women’s Health Diagnostics Market, By Application Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Women’s Health Diagnostics Market, By End Use Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Women’s Health Diagnostics Market, by 2020-2030
Figure 5.3 Leading Country/Regional Women’s Health Diagnostics Market Share, by 2020
Figure 5.4 Leading Country/Regional Women’s Health Diagnostics Market Share, by 2025
Figure 5.5 Leading Country/Regional Women’s Health Diagnostics Market Share, by 2030
Figure 5.6 Europe Women’s Health Diagnostics Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Women’s Health Diagnostics Market, by Forecast 2020-2030
Figure 5.8 Europe Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
Figure 5.9 Europe Women’s Health Diagnostics Submarket , By End Use Forecast 2020-2030
Figure 5.10 Europe Women’s Health Diagnostics Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Women’s Health Diagnostics Submarket , By ZZZZ 2020-2030 ($billion, AGR%)
Figure 5.10 North America Women’s Health Diagnostics Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Women’s Health Diagnostics Market, by Forecast 2020-2030
Figure 5.12 North America Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
Figure 5.13 North America Women’s Health Diagnostics Submarket , By End Use Forecast 2020-2030
Figure 5.14 North America Women’s Health Diagnostics Submarket , By ZZZZ Forecast 2020-2030
Figure 5.13 North America Women’s Health Diagnostics Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Women’s Health Diagnostics Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Women’s Health Diagnostics Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
Figure 5.17 Asia-Pacific Women’s Health Diagnostics Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Women’s Health Diagnostics Submarket , By ZZZZ Forecast 2020-2030
Figure 5.18 Rest of World Women’s Health Diagnostics Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Women’s Health Diagnostics Market, by Forecast 2020-2030
Figure 5.20 Rest of World Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030
Figure 5.21 Rest of World Women’s Health Diagnostics Submarket , By End Use Forecast 2020-2030
Figure 5.21 Rest of World Women’s Health Diagnostics Submarket , By ZZZZ Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Thermo Fisher Scientific, Inc. Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Siemens Aktiengesellschaft Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Dialab Gmbh Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Dialab Gmbh Revenue % Share, by ZZZZ Segment, 2019
Figure 6.8 Dialab Gmbh Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Dialab Gmbh Revenue % Share, by Business Segment, 2019
Figure 6.10 Fujifilm Medical Systems Usa Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Genmark Diagnostics Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Immco Diagnostics Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Immco Diagnostics Revenue % Share, by Regional Segment, 2019
Figure 6.14 Siemens Healthcare GmBH Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Siemens Healthcare GmBH Revenue % Share, by Regional Segment, 2019
Figure 6.16 Siemens Healthcare GmBH Revenue % Share, by Business Segment, 2019
Figure 6.17 Hologic, Inc. Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 GE Healthcare Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 GE Healthcare Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 GE Healthcare Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Women’s Health Diagnostics Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Women’s Health Diagnostics Submarket, By ZZZZ Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Women’s Health Diagnostics Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Women’s Health Diagnostics Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Women’s Health Diagnostics Market Submarket, By ZZZZ Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Women’s Health Diagnostics Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Women’s Health Diagnostics Market Submarket, By ZZZZ Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Women’s Health Diagnostics Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Women’s Health Diagnostics Submarket, By End Use Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Thermo Fisher Scientific, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Thermo Fisher Scientific, Inc. Products and Services (Product/Service, Segment)
Table 6.8 Thermo Fisher Scientific, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Thermo Fisher Scientific, Inc. Total Company Recent Development 2015-2019
Table 6.10 Siemens Aktiengesellschaft Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Siemens Aktiengesellschaft Products and Services (Product/Service, Segment)
Table 6.12 Siemens Aktiengesellschaft Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Siemens Aktiengesellschaft Total Company Recent Development 2015-2019
Table 6.14 Dialab Gmbh Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Dialab Gmbh Products and Services (Product/Service, Segment)
Table 6.16 Dialab Gmbh Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Dialab Gmbh Total Company Recent Development 2015-2019
Table 6.18 Fujifilm Medical Systems Usa Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Fujifilm Medical Systems Usa Products and Services (Product/Service, Segment)
Table 6.20 Fujifilm Medical Systems Usa Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Fujifilm Medical Systems Usa Total Company Recent Development 2015-2019
Table 6.22 Genmark Diagnostics Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Genmark Diagnostics Products and Services (Product/Service, Segment)
Table 6.24 Genmark Diagnostics Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Genmark Diagnostics Total Company Recent Development 2015-2019
Table 6.26 Immco Diagnostics Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Immco Diagnostics Products and Services (Product/Service, Segment)
Table 6.28 Immco Diagnostics Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Immco Diagnostics Total Company Recent Development 2015-2019
Table 6.30 Siemens Healthcare GmBH Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Siemens Healthcare GmBH Products and Services (Product/Service, Segment)
Table 6.32 Siemens Healthcare GmBH Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Siemens Healthcare GmBH Total Company Recent Development 2015-2019
Table 6.34 Hologic, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Hologic, Inc. Products and Services (Product/Service, Segment)
Table 6.36 Hologic, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Hologic, Inc. Total Company Recent Development 2015-2019
Table 6.38 GE Healthcare Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 GE Healthcare Products and Services (Product/Service, Segment)
Table 6.40 GE Healthcare Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 GE Healthcare Total Company Recent Development 2015-2019
Top Companies
Dialab Gmbh
F. Hoffmann-La Roche Ltd
Fujifilm Medical Systems USA
GE Healthcare
Genmark Diagnostics
Hologic, Inc.
Immco Diagnostics
Medgyn Products, Inc.
Siemens Aktiengesellschaft
Siemens Healthcare GmBH
Thermo Fisher Scientific, Inc.
Other Companies
Abbott Laboratories
ALERE
BD
Becton, Dickinson and Company
bioMérieux SA
C. R. BARD INC.
CANON INC.
CARDINAL HEALTH, INC.
CARESTREAM HEALTH INC.
COOK MEDICAL
DANAHER
HITACHI, LTD.
Koninklijke Philips N.V.
LUMINEX CORPORATION
NEUROLOGICA CORP.
NOVA BIOMEDICAL
PerkinElmer, Inc.
Quest Diagnostics, Inc.
ROCHE DIAGNOSTICS
SOMAGEN DIAGNOSTICS
URIT MEDICAL ELECTRONIC CO., LTD
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
